BDBM321270 N-[3-(isoindolin-2-yl)methylamino)propyl]-4-chlorobenzamide::US10179761, Compound 3.1.15
SMILES: Clc1ccc(cc1)C(=O)NCCCNCN1Cc2ccccc2C1
InChI Key: InChIKey=LERQNAUSMXSDPN-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sigma non-opioid intracellular receptor 1 (Homo sapiens (Human)) | BDBM321270![]() (N-[3-(isoindolin-2-yl)methylamino)propyl]-4-chloro...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | 19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITE DE LILLE 2 DROIT ET SANTE; CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) US Patent | Assay Description The σ binding assays were performed according to Ganapathy et al. (Ganapathy, M. E.; Prasad, P. D.; Huang, W.; Seth, P.; Leibach, F. H.; Ganapat... | US Patent US10179761 (2019) BindingDB Entry DOI: 10.7270/Q2NV9MBG | |||||||||||
More data for this Ligand-Target Pair |